Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Braithwaite, S. S.
Right arrow Articles by Hofmann, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Braithwaite, S. S.
Right arrow Articles by Hofmann, C.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 44, Issue 1 43-48, Copyright © 1995 by American Diabetes Association


ARTICLES

Reduced expression of hexokinase II in insulin-resistant diabetes

SS Braithwaite, B Palazuk, JR Colca, CW Edwards and C Hofmann
Medical Service, Edward Hines, Jr. VA Hospital, Hines, Illinois 60141-5000.

The regulation of hexokinase II (HKII) was examined in fat and skeletal muscle of an animal model of non-insulin-dependent diabetes mellitus, the KKAY mouse. These tissues require insulin for facilitated transport of glucose and express the insulin-responsive transporter GLUT4. The combined data from two experiments (n = 12 for each experimental condition) demonstrated mean concentrations of plasma insulin in pmol/l and glucose in mmol/l of 122 and 7.2 (control nondiabetic C57 mouse) vs. 1,118 and 29.6 (diabetic mouse), respectively. The tissues of diabetic mice compared with control mice demonstrated a reduction of HKII mRNA abundance of 68% in epididymal fat (P = 0.0001) and 34% in the quadriceps muscles (P < 0.001), with concordant reduction in the abundance of GLUT4 mRNA of 60% in epididymal fat (P < 0.001). In comparison with the results in untreated diabetic mice, diabetic animals treated with the insulin-sensitizing drug pioglitazone demonstrated an increase in the abundance of HKII mRNA with a concordant increase of GLUT4 mRNA in epididymal fat (P = 0.03 and < 0.01, respectively), and an increase of HKII mRNA in the quadriceps muscles (P < 0.05). Separate experiments demonstrated a reduction of HKII protein abundance by 61% in epididymal fat (P < 0.001, n = 12 for each experimental condition) and by 71% in the quadriceps muscles (P < 0.001, n = 6 for each experimental condition). In comparison with untreated diabetic mice, there was an increase in the abundance of HKII protein in epididymal fat of animals treated with pioglitazone (P < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
P. T. Fueger, R. S. Lee-Young, J. Shearer, D. P. Bracy, S. Heikkinen, M. Laakso, J. N. Rottman, and D. H. Wasserman
Phosphorylation Barriers to Skeletal and Cardiac Muscle Glucose Uptakes in High-Fat Fed Mice: Studies in Mice With a 50% Reduction of Hexokinase II
Diabetes, October 1, 2007; 56(10): 2476 - 2484.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. B. Robey, J. Ma, A. V. P. Santos, O. A. Noboa, P. E. Coy, and J. M. Bryson
Regulation of Mesangial Cell Hexokinase Activity and Expression by Heparin-binding Epidermal Growth Factor-like Growth Factor. EPIDERMAL GROWTH FACTORS AND PHORBOL ESTERS INCREASE GLUCOSE METABOLISM VIA A COMMON MECHANISM INVOLVING CLASSIC MITOGEN-ACTIVATED PROTEIN KINASE PATHWAY ACTIVATION AND INDUCTION OF HEXOKINASE II EXPRESSION
J. Biol. Chem., April 19, 2002; 277(17): 14370 - 14378.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Bryson, P. E. Coy, K. Gottlob, N. Hay, and R. B. Robey
Increased Hexokinase Activity, of Either Ectopic or Endogenous Origin, Protects Renal Epithelial Cells against Acute Oxidant-induced Cell Death
J. Biol. Chem., March 22, 2002; 277(13): 11392 - 11400.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. E. Halseth, D. P. Bracy, and D. H. Wasserman
Limitations to basal and insulin-stimulated skeletal muscle glucose uptake in the high-fat-fed rat
Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E1064 - E1071.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. B. Robey, J. Ma, and A. V. P. Santos
Regulation of mesangial cell hexokinase activity by PKC and the classic MAPK pathway
Am J Physiol Renal Physiol, November 1, 1999; 277(5): F742 - F749.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. W. Cline, K. F. Petersen, M. Krssak, J. Shen, R. S. Hundal, Z. Trajanoski, S. Inzucchi, A. Dresner, D. L. Rothman, and G. I. Shulman
Impaired Glucose Transport as a Cause of Decreased Insulin-Stimulated Muscle Glycogen Synthesis in Type 2 Diabetes
N. Engl. J. Med., July 22, 1999; 341(4): 240 - 246.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P.-Y. Chang, J. Jensen, R. L. Printz, D. K. Granner, J. L. Ivy, and D. E. Moller
Overexpression of Hexokinase II in Transgenic Mice. EVIDENCE THAT INCREASED PHOSPHORYLATION AUGMENTS MUSCLE GLUCOSE UPTAKE
J. Biol. Chem., June 21, 1996; 271(25): 14834 - 14839.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-S. Tsao, R. Burcelin, and M. J. Charron
Regulation of Hexokinase II Gene Expression by Glucose Flux in Skeletal Muscle
J. Biol. Chem., June 21, 1996; 271(25): 14959 - 14963.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1995 by the American Diabetes Association.